Corrigendum to 'Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein' [Pharmacol. Res. 175 (2022) 105975]. (March 2023)

Record Type:
Journal Article
Title:
Corrigendum to 'Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein' [Pharmacol. Res. 175 (2022) 105975]. (March 2023)
Main Title:
Corrigendum to 'Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein' [Pharmacol. Res. 175 (2022) 105975]
Authors:
Abd-ellatef, Gamal Eldein Fathy
Gazzano, Elena
El-Desoky, Ahmed H.
Hamed, Ahmed R.
Kopecka, Joanna
Belisario, Dimas Carolina
Costamagna, Costanzo
Marie, Mohamed Assem S.
Fahmy, Sohair R.
Abdel-Hamid, Abdel-Hamid Z.
Riganti, Chiara
Abstract:
Is Part Of:
Pharmacological research. Volume 189(2023)
Journal:
Pharmacological research
Issue:
Volume 189(2023)
Issue Display:
Volume 189, Issue 2023 (2023)
Year:
2023
Volume:
189
Issue:
2023
Issue Sort Value:
2023-0189-2023-0000
Page Start:
Page End:
Publication Date:
2023-03
Subjects:
Pharmacology -- Periodicals
Pharmacology -- Periodicals
Research -- Periodicals
Médicaments -- Recherche -- Périodiques
Pharmacologie -- Périodiques
615.105
Journal URLs:
http://www.sciencedirect.com/science/journal/10436618 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/j.phrs.2023.106708 ↗
Languages:
English
ISSNs:
1043-6618
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 6446.550000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
26138.xml